Market Research Future

MRFR Validates Global DPT Market to Observe Exorbitant Growth by 2027

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global DPT vaccine Market over the forecast period.


Pune, India -- (SBWIRE) -- 03/19/2018 -- published a Half-Cooked research report on "Global DPT vaccine Market Research Report - Forecast to 2027" reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027.


The report titled "DPT vaccine Market -Forecast to 2027? is a direct appreciation by Market Research Future of the market potential of the DPT vaccine. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today's winner takes all market!

Global DPT vaccine Market - Regional Analysis:

Globally, DPT Vaccine market consists of four regions North America, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market for diphtheria tetanus and pertussis vaccine (DPT) vaccine.

The North American market for DPT Vaccine is expected to grow steadily over the forecasted period. This is due to the presence of high concentration of major market players in North America and its emphasis on vaccination against DPT. North American market consists of countries like the U.S., Canada and Mexico. Death rate sue communicable disease is seen to be growing, thus highlighting the importance of immunization. For instance, In March 2015 U.S FDA approved the use of Quadracel for immunization of children from 4 to 6 years of age. This was a great achievement for Sanofi helping it to maintain its leading position in the market.

Majorly North America is dominating huge part of the market. US, Canada and Mexico are highly contributing in the market growth. Europe is in the second place with countries like UK, Germany some of the major contributor in the global DPT vaccine market. Asia Pacific has countries like China, Japan and India where the population rate is really high. These high population is driving the market growth of DPT vaccine.

Global DPT vaccine Market-Competitive Analysis:

Sanofi Pasteur, the vaccines division of Sanofi announced on March 2015 that the U.S. Food and Drug Administration (FDA) has approved use of Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus; DTaP-IPV) vaccine for active immunization against diphtheria, tetanus, pertussis and poliomyelitis in children 4 through 6 years of age. The FDA approval of Quadracel vaccine provides health care providers with a new mixture vaccine, potentially decreasing the number of vaccine injections children aged 4 through 6 would need.

Major players in this market are: Merck & Co., Inc (U.S), Sanofi (France), GSK (U.S), Lanzhou Institute of Biological Products (China), Wyeth (U.S), Chiron Pharmaceutical Pvt Ltd (India), Serum Institute of India Pvt. Ltd. (India), Lanzhou Institute of Biological Products (China) and others are some of the prominent players at the forefront of competition in the Global DPT vaccine Market and are profiled in MRFR Analysis.

Global Diphtheria Tetanus and Pertussis (DPT) vaccine Market - Overview:

The Global Diphtheria Tetanus and Pertussis Vaccine (DPT) vaccine Market is growing exponentially owing to rising prevalence of chronic disease and increasing usage of combination vaccine and therapy are the major factor driving the DPT vaccine Market. Globally the market for DPT vaccine market is expected to grow at the rate of about 7.3% CAGR from 2016 to 2027.

There is an increase in demand of diphtheria tetanus and pertussis vaccine across the globe and rising awareness regarding prevention of diphtheria, tetanus, and pertussis is major factors which are responsible for the growth of this market. The market is expected to show large opportunities in the coming future with the advancement of technology in developing countries and new products with increased accuracy.

Diverging product markets can be seen in preferences for traditional vaccines such as DTP. According to WHO, developed countries prefer to purchase a component of the DPT vaccines such as procure acellular pertussis (DTaP), while most developing countries purchase vaccines with whole cell pertussis (DTwP) components.

However, some of the challenges which the market is expected to face includes competition from new entrants or big pharmaceutical giants entering the business or market and the continuous advancements in the product. Furthermore there are some hindering factors which are restricting the market growth such as side effects and complications during inhalation, high prices of devices, and lack of accuracy etc.

Europe is the second-largest market for DPT Vaccine which is expected to grow at an overwhelming CAGR during the forecast period. This is due to increasing research and development activities by pharmaceutical companies and research institutes. The market is growing continuously in Europe as the key market players invested huge financial resources on research and development activities for the production of effective vaccines. Increasing awareness about immunization of children against Diphtheria, tetanus and pertussis also drive this market in Europe.

Moreover, Asia Pacific is expected to be the fastest growing market for DPT Vaccine market. India is expected to be the emerging and fastest growing market. Presence of large patient pool drive this market in Asia-pacific. This region is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. Governments in developing countries of Asia-Pacific have undertaken various vaccinations programs. National Health Mission in India provide vaccination against diphtheria, pertussis, tetanus and polio.


The market shows steady growth in Middle East and Africa. In Middle East and Africa the demand for DPT vaccine is less than other regions across the globe.

Immunization to protect against diphtheria, pertussis (whooping cough), and tetanus is jointly known as DPT vaccine. DPT immunizations are given in a series of 5 shots at 2, 4, 6, 18 months of age and 4-6 years of age. Thanks to vaccination programs, these diseases have become less common. Though, there are still unvaccinated persons capable of carrying and passing diphtheria and pertussis to others who are not vaccinated. Tetanus bacteria are prevalent in natural surroundings, such as contaminated soil.

Globally the market for DPT vaccine is increasing rapidly. The major factor that derives the growth of DPT vaccine is the increasing deaths in children due to pertussis. Furthermore increasing awareness for DPT vaccines is increasing the growth of DPT vaccine market. Factors such as high birth rate, demand in number of geriatric population, government initiatives, growth in adoption of DPT vaccination, and government insurance and reimbursement scenario are projected to drive the DPT vaccine market globally.

Diphtheria is a respiratory disease which causes breathing problems, paralysis, heart failure, and death. It's highly transmittable and is spread easily by coughing and sneezing.

Tetanus, is caused by a bacteria often found in soil. Once it enters the body it releases a toxin that attacks the nervous system, causing muscle spasms and finally death.

Pertussis, also extremely contagious, causes coughing spasms so severe that it makes difficult for children to eat, drink even breathe. It can lead to pneumonia, seizures, brain damage, and death.

These three diseases are highly dangerous for a child if not treated properly. This awareness has led the maximum growth of DPT vaccine to protect an infant from these life risky diseases.

On the other hand, factors such as vaccine injuries and opposing event are expected to hinder the growth of the pertussis vaccine market globally.

Global DPT vaccine Market-Segmentation:

Global DPT vaccine market is segmented into 3 divisions:

Segmentation by Type: DPaT, DTwP, Tdap.

Segmentation by Application: Diphtheria, pertussis, tetanus and others.

Segmentation by Region: North America, Europe and Asia Pacific.



About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312